Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Immunooncology

The study of cell surface markers on tumor cells which can be recognized by antibodies, and the development of diagnostic reagents or therapeutic… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
  • H. Ungefroren
  • Expert opinion on therapeutic targets
  • 2019
  • Corpus ID: 195328537
ABSTRACT Introduction: Malignant tumors often escape surveillance and eventual destruction by the host immune system through a… Expand
Review
2018
Review
2018
Immunotherapies are set to become part of the therapeutic repertoire for breast cancer in the near future. Active vaccination is… Expand
2018
2018
Cure, parametric mixture and landmark models may provide more insight into the potential mechanism of action of immunooncology… Expand
Review
2017
Review
2017
  • R. Au
  • Journal of pharmaceutics
  • 2017
  • Corpus ID: 17786102
Immunooncology (IO) is the buzz word today and it has everyone doing IO research. If we look back at the history of cancer… Expand
  • figure 1
  • figure 2
  • table 1
Review
2017
Review
2017
Oncoimmunology (or immunooncology) is a burgeoning specialty of precision (“personalized”) medicine designed to heighten the… Expand
  • table 1
  • figure 1
2017
2017
Cancer immunotherapy is coming of age, as outstanding results can be achieved in the therapy of cancer with poor prognosis by… Expand
Review
2016
Review
2016
Interplay among immune activation and cancer pathogenesis provides the framework for a novel subspecialty known as immunooncology… Expand
  • figure 1
  • figure 2
  • figure 3
Review
2016
Review
2016
Although unlike melanoma, breast cancer is not generally viewed as a highly immunogenic cancer, recent studies have described a… Expand
  • table 1
  • figure 1
  • figure 2
Review
2016
Review
2016
  • M. Grimm
  • Aktuelle Urologie
  • 2016
  • Corpus ID: 4378433
Immune checkpoint inhibitors are establishing itselves as a new systemic treatment option (in addition to chemotherapy and… Expand
2011
2011
Cancer immunology is extremely complex with numerous interactions between the tumor and the host. It is time for those that treat… Expand
  • table 1
  • table 2